Lion's Mane Supplements UK — What the Evidence Says

What is Lion's Mane?

Lion's Mane (Hericium erinaceus) is an edible mushroom native to North America, Europe, and Asia. It grows on hardwood trees and is recognised by its distinctive white, shaggy appearance, which resembles a lion's mane or a cascading waterfall of teeth. It belongs to the tooth fungus group within the family Hericiaceae.

The mushroom has a long history of use in traditional East Asian medicine, particularly in China, Japan, Korea, and India, where it was consumed both as food and as part of herbal practice. Historical texts reference it in the context of digestive health and general vitality, though these traditional uses are distinct from the claims made in modern supplement marketing.

Today, Lion's Mane is sold widely as a dietary supplement, most commonly as a dried powder, capsule, or extract. Supplements are derived from the fruiting body (the visible mushroom), the mycelium (the root-like structure), or a blend of both. The source type matters considerably for supplement quality assessment, and Cogniscore accounts for this in its scoring.

Key Active Compounds

Lion's Mane contains several bioactive compounds that researchers have focused on. The two most studied groups are hericenones and erinacines. Hericenones are found primarily in the fruiting body, while erinacines are found in the mycelium. Both have been examined in preclinical research for their potential relevance to nerve health, though their precise effects in humans remain an active area of study.

Beta-glucans are polysaccharides found in the cell walls of the mushroom. They are a key quality marker for mushroom supplements and are frequently used in research to standardise extracts. A higher beta-glucan percentage generally indicates a more concentrated, better-characterised product. Ergosterol is a precursor compound also present in fungal cell membranes and is sometimes used as a marker of mushroom content in quality testing.

Cogniscore looks for disclosed beta-glucan percentages on product labels and certificates of analysis (COAs) because this is the most practical, publicly verifiable indicator of extract quality. Products that disclose beta-glucan content alongside their source type and extraction method receive higher transparency scores.

Benefit Areas Studied in Research

Cognitive function. Lion's Mane has been studied in human trials for cognitive function. Most of these trials used standardised fruiting body or mycelium extracts over 8 to 16 weeks. Research has examined outcomes such as scores on cognitive assessment tools in older adults, though sample sizes in published trials have generally been small.

Memory. Some studies have used Lion's Mane extracts to examine memory-related outcomes in both animal models and human participants. Animal model research has looked at spatial memory tasks, while human trials have used standardised cognitive tests. The dose range used in these studies typically falls between 500mg and 1,000mg of standardised extract per day.

Focus and mental clarity. A smaller number of studies have examined self-reported measures of focus and mental clarity in healthy adults taking Lion's Mane. Research has looked at questionnaire-based outcomes over periods of four to twelve weeks. This benefit area has less published human trial data than cognitive function or memory.

Nerve health. Preclinical research, including in vitro and animal model studies, has examined Lion's Mane in the context of nerve growth factor (NGF) synthesis. This line of research centres on hericenones and erinacines. Human clinical trials specifically examining nerve health outcomes are more limited, and findings from animal or cell-based models do not transfer directly to human outcomes.

The Science and Research

The published human evidence base for Lion's Mane is small but growing. The studies below represent key trials referenced in the scientific literature. None should be read as proof of efficacy.

Mori et al. (2009), Phytotherapy Research. This was a double-blind, placebo-controlled human RCT conducted in Japan. Researchers examined cognitive function in 30 adults aged 50 to 80 who had been identified with mild cognitive impairment. Participants received 3,000mg per day of dried Lion's Mane fruiting body powder over 16 weeks. Cognitive function was measured using the Hasegawa Dementia Scale. The study had a small sample size and the effect was not maintained four weeks after participants stopped taking the supplement. The trial provides a useful reference point for dose and duration, but the findings cannot be generalised broadly given the population studied and sample size.

Saitsu et al. (2019), Biomedical Research. This was a small human trial examining cognitive function in older adults using Lion's Mane supplements. Participants took a Lion's Mane extract at a dose of approximately 1,000mg per day over 12 weeks. Researchers measured outcomes using cognitive function questionnaires. The study was limited by a very small sample size and lacked a placebo control group, which significantly reduces the weight that can be placed on its findings.

Li et al. (2020), Journal of Medicinal Food. This was a review paper examining the neurohealth properties of Hericium erinaceus across multiple study types. The authors surveyed in vitro research, animal model studies, and the limited human trial data available at the time. The review covers the mechanistic basis for research interest in hericenones and erinacines. As a review rather than a primary trial, it does not itself constitute evidence of efficacy but provides a useful summary of the research landscape up to 2020.

Across these studies, the dose range most commonly used in human trials is 500mg to 3,000mg per day of dried extract, with most trials running for 8 to 16 weeks. The majority of human studies are small, and several lack adequate placebo controls. Animal and in vitro studies, while mechanistically interesting, do not confirm human outcomes.

How Cogniscore Evaluates Lion's Mane

Cogniscore scores Lion's Mane products against several specific criteria. Dose per serving is assessed against the range used in published human clinical trials, which runs from 500mg to 3,000mg of dried extract per day. Products delivering less than 500mg per serving fall below the dose range used in clinical research, and this affects their score. Products delivering 500mg to 2,000mg per serving score more favourably on the dose dimension.

Source type is scored separately. Fruiting body extracts score more favourably than mycelium-only products, because the compounds most studied in human trials (hericenones in particular) are concentrated in the fruiting body. Dual-extract products that clearly disclose both source and extraction method receive additional transparency credit. Beta-glucan percentage is a key disclosure marker: products that publicly state a verified beta-glucan figure on their label or COA score higher than those that do not. Third-party COA availability is also scored as an indicator of testing transparency. Full details are set out in the full Cogniscore methodology.

Top Rated Products Containing Lion's Mane

Ranked by Cogniscore — highest disclosure scores first. Scores reflect what brands publicly disclose, not product quality or efficacy.

Frequently Asked Questions